News
Adjusted EPS: $6.94 vs analyst estimates of $6.72 (3.2% beat) Adjusted EBITDA: $1.29 billion vs analyst estimates of $1.29 billion (26% margin, in line) Management slightly raised its full-year ...
CFO Joan Hooper pointed to record margins in Device Solutions and improved recurring revenue in Outcomes as supporting factors for margin growth, despite revenue coming in flat compared to the ...
Super Micro Computer stock has been on a tear, surging over 33% in just the past two trading days following a notable analyst ...
LUANDA, May 13 (Reuters) - A loan to Angola from JPMorgan, which was the subject of a $200 million margin call during a market selloff caused by U.S. trade tariffs, cost just below 9%, the finance ...
Despite a 3.5% decline in revenue, the company’s focus on high-margin revenue streams has bolstered its financial standing. Following the earnings announcement, Viq Solutions’ stock decreased ...
as mentioned in the conference call. If interest rates fall, then deposit costs could decline, thereby boosting the margin. BWB’s deposit base is more sensitive to changing interest rates ...
Revenue: $4.05 billion vs analyst estimates of $4.26 billion (8.3% year-on-year decline, 4.9% miss) Adjusted EPS: $1.17 vs analyst estimates of $1.05 (11.4% beat) Adjusted EBITDA: $211.1 million vs ...
The gross margin has continued to recover significantly ... but also growth in the Hard Mountain Dew drink and Twisted Tea. In the Q1 earnings call, management expressed that the Sun Cruiser ...
Despite the drop in sales, the company improved its gross margin to 16.8% from 13.6% a year earlier. The company also reported a net loss of $988,000, or $0.27 per share, compared to a loss of ...
The company, known for its CBD products, faced a decline in unit sales but managed to enhance its gross margin. According to InvestingPro analysis, CV Sciences currently trades near its 52-week low, ...
If your account falls below this level, you’ll face a margin call, requiring you to deposit more funds or sell off assets to bring your account back into compliance. Investors must pay interest ...
The company, known for its CBD products, faced a decline in unit sales but managed to enhance its gross margin. According to InvestingPro analysis, CV Sciences currently trades near its 52-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results